Osteoarthritis

Osteoarthritis
Name	Osteoarthritis

Osteoarthritis is a condition characterized by the breakdown of cartilage in joints, leading to bone-on-bone contact and resulting in pain, stiffness, and limited mobility, as described by Hippocrates, Galen, and Andreas Vesalius. It is a major cause of disability and morbidity in older adults, affecting millions of people worldwide, including United States, Europe, and Australia. The condition is often associated with aging, obesity, and trauma, as noted by Centers for Disease Control and Prevention and World Health Organization. Osteoarthritis has been studied extensively by researchers at Harvard University, Stanford University, and University of California, Los Angeles.

Definition and Classification

Osteoarthritis is defined as a degenerative joint disease characterized by the breakdown of articular cartilage and underlying bone, as described by American College of Rheumatology and European League Against Rheumatism. It can be classified into different types, including primary and secondary osteoarthritis, with primary osteoarthritis being the most common form, affecting knee and hip joints, as seen in patients at Mayo Clinic and Cleveland Clinic. The classification of osteoarthritis is based on the location and severity of the disease, with Kellgren-Lawrence grading system being widely used, as adopted by National Institutes of Health and Food and Drug Administration. Researchers at University of Oxford and University of Cambridge have made significant contributions to the understanding of osteoarthritis classification.

Causes and Risk Factors

The causes of osteoarthritis are multifactorial, involving a combination of genetic, environmental, and lifestyle factors, as studied by National Institute of Arthritis and Musculoskeletal and Skin Diseases and Arthritis Foundation. Risk factors for osteoarthritis include age, obesity, trauma, and family history, as noted by Centers for Disease Control and Prevention and World Health Organization. Other risk factors include occupational hazards, such as repetitive joint stress, and sports injuries, as seen in athletes at Olympic Games and National Football League. Researchers at Harvard University and Stanford University have identified several genetic variants associated with an increased risk of osteoarthritis, including IL1B and TNF.

Pathophysiology

The pathophysiology of osteoarthritis involves the breakdown of articular cartilage and underlying bone, leading to the formation of osteophytes and subchondral sclerosis, as described by American Academy of Orthopaedic Surgeons and Orthopaedic Research Society. The disease process is characterized by an imbalance between cartilage synthesis and degradation, with an increase in pro-inflammatory cytokines, such as IL-1beta and TNF-alpha, as studied by researchers at University of California, San Francisco and University of Pennsylvania. The role of stem cells and growth factors in the pathogenesis of osteoarthritis is an area of active research, with studies being conducted at University of California, Los Angeles and University of Michigan.

Symptoms and Diagnosis

The symptoms of osteoarthritis include pain, stiffness, and limited mobility, as well as crepitus and instability, as noted by American College of Rheumatology and European League Against Rheumatism. The diagnosis of osteoarthritis is based on a combination of clinical evaluation, imaging studies, such as X-ray and magnetic resonance imaging, and laboratory tests, such as blood and synovial fluid analysis, as performed at Mayo Clinic and Cleveland Clinic. Researchers at University of Oxford and University of Cambridge have developed several diagnostic criteria for osteoarthritis, including the American College of Rheumatology criteria.

Treatment and Management

The treatment and management of osteoarthritis involve a combination of non-pharmacological and pharmacological interventions, as recommended by American College of Rheumatology and European League Against Rheumatism. Non-pharmacological interventions include exercise, weight loss, and physical therapy, as well as assistive devices, such as canes and walkers, as used by patients at Rehabilitation Institute of Chicago and Spaulding Rehabilitation Hospital. Pharmacological interventions include analgesics, such as acetaminophen and ibuprofen, as well as disease-modifying osteoarthritis drugs, such as glucosamine and chondroitin, as prescribed by doctors at Massachusetts General Hospital and University of California, San Francisco. Researchers at Harvard University and Stanford University are exploring new treatments for osteoarthritis, including stem cell therapy and gene therapy.

Epidemiology

Osteoarthritis is a major public health problem, affecting millions of people worldwide, with a significant impact on quality of life and healthcare costs, as noted by World Health Organization and Centers for Disease Control and Prevention. The prevalence of osteoarthritis increases with age, with the majority of cases occurring in people over the age of 65, as seen in studies conducted at University of California, Los Angeles and University of Michigan. The disease is more common in women than men, and in people with a family history of osteoarthritis, as reported by researchers at University of Oxford and University of Cambridge. Osteoarthritis is a significant burden on healthcare systems, with estimated annual costs of over $100 billion in the United States alone, as estimated by National Institutes of Health and Food and Drug Administration.

Category:Medical conditions